Clinical Trial Update: Recombinant Factor VIIa in Acute Intracerebral Haemorrhage [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of Recombinant Factor VIIa in acute intracerebral hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• Recombinant Factor VIIa (recombinant activated factor VII)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Acquired Bleeding Disorder, Intracerebral Haemorrhage | Phase 3 | Status: COMPLETED